Citigroup
CANO

Citigroup’s Cano Health, Inc. CANO Stock Holding History

Citigroup’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,500
Closed -$3.17M – 6155
2021
Q3 		$3.17M Buy
+2,500
New +$3.03M ﹤0.01% 2140

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Citigroup's CANO Position: Q1 2024 in Review

Citigroup sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 348 shares — an estimated $2.04K sold.

Citigroup first reported a position in CANO in Q4 2020 and held it in 12 quarters. The position peaked at $17.4M in Q3 2021. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Citigroup reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Citigroup sold 348 Cano Health, Inc. shares in Q1 2024, an estimated $2.04K.
  • Citigroup first reported a position in Cano Health, Inc. in Q4 2020 and held it in 12 quarters.
  • Citigroup's Cano Health, Inc. position peaked at $17.4M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.